Medtech activated its first sub-retinal implant (Prima) in a patient with atrophic dry AMD. The shares of the medtech gain about 25% this 26 of January at the end of the morning.
Medtech activated its first sub-retinal implant (Prima) in a patient with atrophic dry AMD. The shares of the medtech gain about 25% this 26 of January at the end of the morning.